GlassScriptPhysician profile
Albert T Peng
NPI 1609862820
$7,384.86
in general payments reported to CMS, 2019-2025
32 companies · $1,902 in 2025
The $1,902 reported for 2025 was more than what 87% of Mohs-Micrographic Surgery providers received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,250 · 2020: $176 · 2021: $356 · 2022: $588 · 2023: $1,006 · 2024: $2,107 · 2025: $1,902.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,707 · Education: $308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,706.76 |
| Education | $308.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,105.26 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $683.62 | 2019-2025 | |
| Lilly USA, LLC | $633.88 | 2020-2025 | Taltz, Ebglyss, Olumiant |
| Janssen Biotech, INC. | $624.71 | 2021-2025 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $594.18 | 2019-2025 | Dupixent, Libtayo |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $442.30 | 2019-2025 | Siliq, Jublia |
| Amgen INC. | $410.13 | 2020-2025 | Otezla, Otezla |
| Mimedx Group, INC. | $391.88 | 2024-2025 | |
| Galderma Laboratories, L.P. | $293.34 | 2019-2025 | Nemluvio |
| Pfizer INC. | $285.58 | 2019-2025 | |
| Ucb, INC. | $270.80 | 2023-2025 | Bimzelx |
| Arcutis Biotherapeutics, INC. | $235.57 | 2023-2025 | Zoryve |
| Sun Pharmaceutical Industries INC. | $230.85 | 2019-2024 | Ilumya, Winlevi, Absorica Ld |
| Incyte Corporation | $160.69 | 2023-2025 | Opzelura |
| Genentech USA, INC. | $148.90 | 2019-2024 | Erivedge |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biofrontera INC. | $119.92 | 2019-2025 | Xepi, Bf-Rhodoled, Ameluz |
| E.R. Squibb & Sons, L.L.C. | $100.95 | 2023-2024 | Sotyktu |
| Janssen Scientific Affairs, LLC | $99.77 | 2019 | |
| Leo Pharma INC. | $78.24 | 2022-2025 | Adbry |
| Genzyme Corporation | $77.73 | 2022-2025 | |
| Fresenius Kabi USA, LLC | $60.88 | 2023-2024 | Idacio |
| Almirall LLC | $55.97 | 2025 | Klisyri |
| Kyowa Kirin, INC. | $46.69 | 2022-2023 | Poteligeo |
| Organon LLC | $38.21 | 2024-2025 | |
| Stryker Corporation | $36.07 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Chiesi USA, INC. | $33.59 | 2025 | Filsuvez |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.20 | 2022 | |
| Akcea Therapeutics, INC. | $25.61 | 2019 | |
| Botanix Sb INC | $24.76 | 2025 | Sofdra |
| Smith+Nephew, INC. | $21.21 | 2024 | Grafix Pl |
| Dermavant Sciences, INC. | $14.56 | 2023 | Vtama |
| Allergan, INC. | $12.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Peng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.